Mediolanum International Funds Ltd Buys 1,602 Shares of Mettler-Toledo International, Inc. $MTD

Mediolanum International Funds Ltd lifted its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 38.2% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 5,801 shares of the medical instruments supplier’s stock after purchasing an additional 1,602 shares during the period. Mediolanum International Funds Ltd’s holdings in Mettler-Toledo International were worth $6,872,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in MTD. Bank of New York Mellon Corp raised its position in Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after acquiring an additional 376,419 shares in the last quarter. Alliancebernstein L.P. increased its stake in shares of Mettler-Toledo International by 21.6% during the 1st quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after purchasing an additional 126,147 shares during the last quarter. PineStone Asset Management Inc. increased its stake in shares of Mettler-Toledo International by 41.9% during the 2nd quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock worth $392,766,000 after purchasing an additional 98,737 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Mettler-Toledo International by 42.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock valued at $361,030,000 after purchasing an additional 90,395 shares during the period. Finally, Nuveen LLC acquired a new stake in Mettler-Toledo International in the 1st quarter valued at about $71,897,000. 95.07% of the stock is owned by institutional investors.

Mettler-Toledo International Price Performance

MTD stock opened at $1,454.06 on Friday. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,471.06. The stock has a market capitalization of $29.70 billion, a price-to-earnings ratio of 36.82, a PEG ratio of 4.19 and a beta of 1.41. The business’s fifty day moving average price is $1,347.64 and its two-hundred day moving average price is $1,261.26.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, beating the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a net margin of 21.46% and a negative return on equity of 476.07%. The business had revenue of $1.03 billion for the quarter, compared to the consensus estimate of $997.36 million. During the same period in the prior year, the company posted $10.21 earnings per share. Mettler-Toledo International’s revenue was up 7.9% compared to the same quarter last year. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Research analysts expect that Mettler-Toledo International, Inc. will post 42.71 EPS for the current year.

Insider Buying and Selling at Mettler-Toledo International

In related news, CFO Shawn Vadala sold 1,895 shares of the stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $1,455.52, for a total transaction of $2,758,210.40. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,696,789.76. This represents a 26.38% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider La Guerroniere Marc De sold 6,880 shares of Mettler-Toledo International stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the completion of the transaction, the insider directly owned 187 shares of the company’s stock, valued at $271,150. This represents a 97.35% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 11,249 shares of company stock valued at $16,338,723 over the last ninety days. Company insiders own 1.94% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on MTD. Wells Fargo & Company boosted their price target on Mettler-Toledo International from $1,200.00 to $1,400.00 and gave the stock an “equal weight” rating in a research report on Monday, November 10th. Bank of America increased their price target on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Evercore ISI lifted their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Citigroup upped their price objective on shares of Mettler-Toledo International from $1,600.00 to $1,700.00 and gave the company a “buy” rating in a report on Monday, November 10th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Mettler-Toledo International in a report on Wednesday, October 8th. Five equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $1,406.50.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.